HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 39871,
"recordsTotal": 39871,
"next": null,
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=39300",
"results": [
{
"registry_id": "NCT06034821",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06034821",
"title": "Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)",
"has_exemption": false,
"start_date": "2023-10-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06068543",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06068543",
"title": "A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06214793",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06214793",
"title": "A Phase II Study of Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) of the Breast (TaCe)",
"has_exemption": false,
"start_date": "2024-04-30",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Megan Kruse, MD",
"sponsor_slug": "megan-kruse-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05948943",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05948943",
"title": "A Two-stage Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.",
"has_exemption": false,
"start_date": "2023-11-24",
"completion_date": "2030-01-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00109174",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00109174",
"title": "MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain",
"has_exemption": false,
"start_date": "2006-09-06",
"completion_date": "2030-01-11",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Mental Health (NIMH)",
"sponsor_slug": "national-institute-of-mental-health-nimh",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05212246",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05212246",
"title": "CSP #2019 - Basal Cell Carcinoma Chemoprevention Trial (B3C)",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2030-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05800015",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05800015",
"title": "A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody), Cemiplimab (Anti-PD-1 Antibody), and Chemotherapy Versus Cemiplimab and Chemotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Irrespective of PD-L1 Expression Levels",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2030-01-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01687608",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01687608",
"title": "A Phase 1/2 Open-Label, Single Ascending Dose Trial of a Self-Complementing Optimized Adeno-associated Virus Serotype 8 Factor IX Gene Therapy (AskBio009) in Adults With Hemophilia B",
"has_exemption": false,
"start_date": "2013-02-11",
"completion_date": "2030-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Baxalta now part of Shire",
"sponsor_slug": "baxalta-now-part-of-shire",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05291234",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05291234",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ABBV-916 in Subjects With Early Alzheimer's Disease",
"has_exemption": false,
"start_date": "2022-08-15",
"completion_date": "2030-01-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06097364",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06097364",
"title": "A Phase 3, Open-Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20x Anti-CD3 Bispecific Antibody, Combined With Chemotherapy Versus Rituximab Combined With Chemotherapy in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-2)",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2030-01-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00785525",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00785525",
"title": "Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors",
"has_exemption": false,
"start_date": "1997-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Center for International Blood and Marrow Transplant Research",
"sponsor_slug": "center-for-international-blood-and-marrow-transplant-research",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01538056",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01538056",
"title": "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study",
"has_exemption": false,
"start_date": "2011-03-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03599752",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03599752",
"title": "The Role of Multimodality Management in Risk-Stratified Patients With Lung-Limited Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2018-07-02",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05643742",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05643742",
"title": "A Phase 1/2, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Subjects With Relapsed or Refractory B Cell Malignancies",
"has_exemption": false,
"start_date": "2023-03-10",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics AG",
"sponsor_slug": "crispr-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06193551",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06193551",
"title": "Ovitex in Paraesophageal and Large Hiatal Hernia Repair. (OviPHeR)",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Foregut Research Foundation",
"sponsor_slug": "foregut-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157892",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06157892",
"title": "A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination With Other Anticancer Therapies in Solid Tumors",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Seagen Inc.",
"sponsor_slug": "seagen-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00001379",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00001379",
"title": "Treatment and Natural History Study of Lymphomatoid Granulomatosis",
"has_exemption": false,
"start_date": "1995-05-05",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01754363",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01754363",
"title": "Short, Medium and Long Term Survivorship of Attune Primary Knee Prosthesis",
"has_exemption": false,
"start_date": "2013-02-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "DePuy International",
"sponsor_slug": "depuy-international",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03735095",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03735095",
"title": "Endobronchial Ultrasound Transbronchial Needle Guided Interstitial Photodynamic Therapy for Palliation of Locally Advanced Lung Cancer and Advanced Cancers Obstructing the Airway -Phase I/II",
"has_exemption": false,
"start_date": "2020-02-12",
"completion_date": "2030-02-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05608291",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05608291",
"title": "A Phase 3 Trial of Fianlimab (Anti-LAG-3) and Cemiplimab Versus Pembrolizumab in the Adjuvant Setting in Patients With Completely Resected High-risk Melanoma",
"has_exemption": false,
"start_date": "2023-01-16",
"completion_date": "2030-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00338377",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00338377",
"title": "Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma",
"has_exemption": false,
"start_date": "2006-02-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02912312",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02912312",
"title": "Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized Trial of Hypofractionated Versus Conventionally Fractionated Regional Nodal Irradiation for Invasive Breast Cancer",
"has_exemption": false,
"start_date": "2017-02-23",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03726554",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03726554",
"title": "Comprehensive Reverse Shoulder: Porous Augmented Glenoid Baseplate and Mini Humeral Tray Post-Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408352",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04408352",
"title": "Selective Bladder Denervation Using RF Energy for the Treatment of UUI",
"has_exemption": false,
"start_date": "2020-04-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hologic, Inc.",
"sponsor_slug": "hologic-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06150183",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06150183",
"title": "A First-in-Human, Open-label, Dose Escalation Trial With Expansion Cohorts to Evaluate the Safety and Preliminary Efficacy of BNT314 in Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Patients With Advanced Malignant Solid Tumors",
"has_exemption": false,
"start_date": "2023-11-30",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04402073",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04402073",
"title": "Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma (PersoMed-I)",
"has_exemption": false,
"start_date": "2022-11-11",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "European Organisation for Research and Treatment of Cancer - EORTC",
"sponsor_slug": "european-organisation-for-research-and-treatment-of-cancer-eortc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952557",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05952557",
"title": "CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease",
"has_exemption": false,
"start_date": "2023-10-05",
"completion_date": "2030-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03148418",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03148418",
"title": "An Open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study",
"has_exemption": false,
"start_date": "2017-09-20",
"completion_date": "2030-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05837897",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05837897",
"title": "A Phase 3, Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-Controlled Induction Study Followed by an Open-label Extension Period to Evaluate the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Subjects in China With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2023-06-16",
"completion_date": "2030-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05432791",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05432791",
"title": "A Randomized Phase 2/3 Study of Olaparib Plus Temozolomide Versus Investigator's Choice for the Treatment of Patients With Advanced Uterine Leiomyosarcoma After Progression on Prior Chemotherapy",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2030-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05785767",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05785767",
"title": "A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody) in Combination With Cemiplimab (Anti-PD-1 Antibody) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%",
"has_exemption": false,
"start_date": "2023-06-30",
"completion_date": "2030-03-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05691478",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05691478",
"title": "A Feasibility and Randomized Phase 2/3 Study of the VEFGR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma",
"has_exemption": false,
"start_date": "2023-03-03",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04064060",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04064060",
"title": "A Phase 3b, Open-label, Single-arm, Rollover Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials",
"has_exemption": false,
"start_date": "2019-08-12",
"completion_date": "2030-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01208389",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01208389",
"title": "A Follow-On Study to Evaluate the Safety of Re-Administration of Adeno-Associated Viral Vector Containing the Gene for Human RPE65 [AAV2-hRPE65v2] to the Contralateral Eye in Subjects With Leber Congenital Amaurosis (LCA) Previously Enrolled in a Phase 1 Study",
"has_exemption": false,
"start_date": "2010-11-30",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Spark Therapeutics",
"sponsor_slug": "spark-therapeutics",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02050113",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02050113",
"title": "Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices",
"has_exemption": false,
"start_date": "2014-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Andres Schanzer",
"sponsor_slug": "andres-schanzer",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03048201",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03048201",
"title": "Post-market Registry Study on the Physica System Total Knee Replacement",
"has_exemption": false,
"start_date": "2017-03-24",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Limacorporate S.p.a",
"sponsor_slug": "limacorporate-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05561387",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05561387",
"title": "A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of \"Intermediate Fit\" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance",
"has_exemption": false,
"start_date": "2023-10-12",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06153173",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06153173",
"title": "A Phase II Trial of the MEK Inhibitor Mirdametinib in Histiocytic Disorders",
"has_exemption": false,
"start_date": "2024-02-05",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06013865",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06013865",
"title": "An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04387305",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04387305",
"title": "Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): An Efficacy Study",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Nishijima, MD, MAS",
"sponsor_slug": "daniel-nishijima-md-mas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04042402",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04042402",
"title": "An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria",
"has_exemption": false,
"start_date": "2019-07-09",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",
"sponsor_slug": "dicerna-pharmaceuticals-inc-a-novo-nordisk-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04303169",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04303169",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02C",
"has_exemption": false,
"start_date": "2020-06-26",
"completion_date": "2030-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04305041",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04305041",
"title": "A Phase 1/2 Open-label Rolling-arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02A",
"has_exemption": false,
"start_date": "2020-06-26",
"completion_date": "2030-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04305054",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04305054",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02B",
"has_exemption": false,
"start_date": "2020-07-01",
"completion_date": "2030-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04700072",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04700072",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02D",
"has_exemption": false,
"start_date": "2021-05-03",
"completion_date": "2030-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04060277",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04060277",
"title": "A Phase II Randomized, Placebo-Controlled, Multicenter Trial to Evaluate the Protective Function of CMV-MVA Triplex Vaccine in Adult Recipients of Haploidentical Hematopoietic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2019-11-27",
"completion_date": "2030-04-07",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05521997",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05521997",
"title": "Phase II Study of Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2030-04-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03718403",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03718403",
"title": "Effect of Theophylline in Pseudohypoparathyroidism",
"has_exemption": false,
"start_date": "2019-11-11",
"completion_date": "2030-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06188741",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06188741",
"title": "Phase 2 Trial of Selumetinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Neurofibromatosis Type 1",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2030-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06241573",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06241573",
"title": "Lunsayil LTE: An Extension Trial Assessing Long-term Spesolimab Treatment in Patients With Hidradenitis Suppurativa (HS)",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2030-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01817517",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01817517",
"title": "Phase 1 Study of Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome",
"has_exemption": false,
"start_date": "2014-03-31",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03535298",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03535298",
"title": "Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis",
"has_exemption": false,
"start_date": "2019-01-03",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Cleveland Clinic",
"sponsor_slug": "the-cleveland-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04806854",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04806854",
"title": "A Single-Center, Randomized, Open-Label, Parallel Arm Study of Daily Oral LUM-201 in Naive-to-Treatment, Prepubertal Children With Idiopathic Pediatric Growth Hormone Deficiency (PGHD)",
"has_exemption": false,
"start_date": "2021-07-14",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05795595",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05795595",
"title": "A Phase 1/2, Open-label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed or Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2023-03-13",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics AG",
"sponsor_slug": "crispr-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714085",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05714085",
"title": "A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)",
"has_exemption": false,
"start_date": "2023-05-31",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03346694",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03346694",
"title": "Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing",
"has_exemption": false,
"start_date": "2018-05-01",
"completion_date": "2030-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05692180",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05692180",
"title": "Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)",
"has_exemption": false,
"start_date": "2023-04-05",
"completion_date": "2030-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05775367",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05775367",
"title": "Cochlear Implantation in Infants and Toddlers With Single-Sided Deafness",
"has_exemption": false,
"start_date": "2023-07-07",
"completion_date": "2030-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05563948",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05563948",
"title": "Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2030-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02736695",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02736695",
"title": "Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and FTD",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04900623",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04900623",
"title": "Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study",
"has_exemption": false,
"start_date": "2021-07-02",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonathan Schoenfeld, MD, MPH",
"sponsor_slug": "jonathan-schoenfeld-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04007276",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04007276",
"title": "The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients Using Brimonidine 0.2%, 0.15%, or 0.1%",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2030-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Tulane University",
"sponsor_slug": "tulane-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05998408",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05998408",
"title": "A Phase I/II Study of the JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2030-06-03",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04589650",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04589650",
"title": "EPIK-P2: A Phase II Double-blind Study With an Upfront, 16-week Randomized, Placebo-controlled Period, to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)",
"has_exemption": false,
"start_date": "2021-04-19",
"completion_date": "2030-06-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05367440",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05367440",
"title": "A Multi-arm, Open-label Phase I/IIa Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of AZD5305 in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)",
"has_exemption": false,
"start_date": "2022-06-02",
"completion_date": "2030-06-07",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06077760",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06077760",
"title": "A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2023-12-06",
"completion_date": "2030-06-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04004169",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04004169",
"title": "Closed-Loop Deep Brain Stimulation for Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2019-07-18",
"completion_date": "2030-06-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrew Krystal",
"sponsor_slug": "andrew-krystal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05422222",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05422222",
"title": "A Phase 3 Study Evaluating the Pharmacokinetics, Safety, and Tolerability of VX-121/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Through 11 Years of Age",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06122974",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06122974",
"title": "A RanDomized Controlled Trial of the Drug Eluting TEmporary Spur StEnt System vs PERcutaneous Balloon Angioplasty for the TReatment of CriTical Limb Ischemia",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ReFlow Medical, Inc.",
"sponsor_slug": "reflow-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06131502",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06131502",
"title": "ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy for Treatment of Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2024-06-30",
"completion_date": "2030-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05564377",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05564377",
"title": "Molecular Analysis for Combination Therapy Choice (ComboMATCH)",
"has_exemption": false,
"start_date": "2023-04-07",
"completion_date": "2030-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684602",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04684602",
"title": "Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions",
"has_exemption": false,
"start_date": "2020-07-09",
"completion_date": "2030-07-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Advanced Medical LLC",
"sponsor_slug": "thomas-advanced-medical-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06054230",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06054230",
"title": "Genomic Sequencing for Evaluation of Fetal Structural Anomalies",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2030-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06022939",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06022939",
"title": "A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients With Newly Diagnosed AL Amyloidosis",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2030-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04844606",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04844606",
"title": "A Master Protocol for a Phase 3, Multicenter, Open-label, Long-term Extension Study to Evaluate the Long-term Efficacy and Safety of Mirikizumab in Children and Adolescents With Moderate-to-severe Ulcerative Colitis or Crohn's Disease",
"has_exemption": false,
"start_date": "2021-05-26",
"completion_date": "2030-07-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02524834",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02524834",
"title": "Proposed Single Center Investigational Device Exemption: Endovascular Repair of Descending ThoracoAbdominal Aortic Pathologies Using Physician Modified Endovascular Prosthesis",
"has_exemption": false,
"start_date": "2015-07-31",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rodney A. White, M.D.",
"sponsor_slug": "rodney-a-white-md",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05145127",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05145127",
"title": "AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF MARSTACIMAB PROPHYLAXIS IN SEVERE (COAGULATION FACTOR ACTIVITY <1%) HEMOPHILIA A PARTICIPANTS WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS",
"has_exemption": false,
"start_date": "2021-11-17",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05469893",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05469893",
"title": "Immuno-PRISM (PRecision Intervention Smoldering Myeloma): A Randomized Phase II Platform Study of Select Immunotherapies for High-Risk Smoldering Myeloma",
"has_exemption": false,
"start_date": "2022-08-10",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Irene Ghobrial, MD",
"sponsor_slug": "irene-ghobrial-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072131",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06072131",
"title": "A Phase 3, Randomized, Open-Label Study Comparing the Efficacy and Safety of the Combination of Beleodaq-CHOP or Folotyn-COP to the CHOP Regimen Alone in Newly Diagnosed Patients With Peripheral T-Cell Lymphoma",
"has_exemption": false,
"start_date": "2023-10-04",
"completion_date": "2030-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Acrotech Biopharma Inc.",
"sponsor_slug": "acrotech-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05737693",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05737693",
"title": "Posttraumatic Stress Disorder (PTSD) Treatment: Using Ketamine to Enhance Memory Reconsolidation and Extinction of Overgeneralized Fear in Individuals Diagnosed With PTSD",
"has_exemption": false,
"start_date": "2023-08-21",
"completion_date": "2030-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05788536",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05788536",
"title": "A PHASE 1/2, OPEN-LABEL, MULTICENTER TRIAL WITH A SINGLE ASCENDING DOSE COHORT WITH UNILATERAL INTRACOCHLEAR INJECTION FOLLOWED BY A BILATERAL INJECTION EXPANSION COHORT TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF DB-OTO IN CHILDREN AND INFANTS WITH BIALLELIC hOTOF MUTATIONS",
"has_exemption": false,
"start_date": "2023-05-12",
"completion_date": "2030-08-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Decibel Therapeutics",
"sponsor_slug": "decibel-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05983276",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05983276",
"title": "Combination of the Hypomethylating Agent Decitabine and the Nuclear Export Receptor XPO-1 Inhibitor Selinexor to Reverse Platinum Resistance in Relapsed/Refractory Epithelial Ovarian Cancer",
"has_exemption": false,
"start_date": "2023-11-16",
"completion_date": "2030-08-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Loyola University",
"sponsor_slug": "loyola-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01654133",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01654133",
"title": "Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts",
"has_exemption": false,
"start_date": "2012-07-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02372409",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02372409",
"title": "A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors",
"has_exemption": false,
"start_date": "2015-08-14",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06007677",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06007677",
"title": "A Phase 2 Long-Term Open-Label Trial to Assess the Safety and Efficacy of Repeat Dosing of STAR-0215 in Adult Patients With Hereditary Angioedema (The ALPHA-SOLAR Trial)",
"has_exemption": false,
"start_date": "2023-09-26",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astria Therapeutics, Inc.",
"sponsor_slug": "astria-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05487599",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05487599",
"title": "An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2030-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06109272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06109272",
"title": "A Phase 2/3, Randomized Study to Evaluate the Dose Optimization, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab in Subjects With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) Who Have Not Previously Received Systemic Treatment",
"has_exemption": false,
"start_date": "2024-01-11",
"completion_date": "2030-09-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02559778",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02559778",
"title": "A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Subjects With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2015-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04584853",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04584853",
"title": "PreOperative Endocrine Therapy for Individualised Care With Abemaciclib",
"has_exemption": false,
"start_date": "2020-12-23",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Institute of Cancer Research, United Kingdom",
"sponsor_slug": "institute-of-cancer-research-united-kingdom",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04685616",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04685616",
"title": "A Randomised Phase III Trial With a PET Response Adapted Design Comparing ABVD +/- ISRT With A2VD +/- ISRT in Patients With Previously Untreated Stage IA/IIA Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University College, London",
"sponsor_slug": "university-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05509595",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05509595",
"title": "A Phase 2 Study of Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia",
"has_exemption": false,
"start_date": "2022-12-07",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Dental and Craniofacial Research (NIDCR)",
"sponsor_slug": "national-institute-of-dental-and-craniofacial-research-nidcr",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06037356",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06037356",
"title": "Prostatic Urethral Lift Versus Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients With Urinary Retention",
"has_exemption": false,
"start_date": "2023-10-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Queen Mary Hospital, Hong Kong",
"sponsor_slug": "queen-mary-hospital-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06016842",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06016842",
"title": "A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of Elafibranor 80 mg on Long-Term Clinical Outcomes in Adult Participants With Primary Biliary Cholangitis (PBC)",
"has_exemption": false,
"start_date": "2023-08-31",
"completion_date": "2030-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05678959",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05678959",
"title": "A Three-year, Multi-center, Double-blind, Extension Study to Evaluate the Long-term Safety and Efficacy of Ligelizumab in Patients Who Completed Ligelizumab's Phase III Studies in Food Allergy",
"has_exemption": false,
"start_date": "2023-04-27",
"completion_date": "2030-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04062266",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04062266",
"title": "Phase II Study of 5-Azacytidine (AZA) + Venetoclax as Maintenance Therapy in Patients With AML in Remission",
"has_exemption": false,
"start_date": "2019-09-13",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05844449",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05844449",
"title": "A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Year of Age and Older",
"has_exemption": false,
"start_date": "2023-08-11",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933395",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05933395",
"title": "Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05991388",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05991388",
"title": "A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Birmingham",
"sponsor_slug": "university-of-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06121180",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06121180",
"title": "A Phase II Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04483544",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04483544",
"title": "Immunotherapy in Combination With PARP Inhibition in Advanced Cervical Cancer Patients Functionally Competent or Deficient for the Fanconi Anemia Repair Pathway",
"has_exemption": false,
"start_date": "2020-12-03",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06211764",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06211764",
"title": "A Phase 3, Randomized, Open-label, Multi-center Study Evaluating the Efficacy and Safety of TAR-200 Versus Investigator's Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High-risk Non-muscle-invasive Bladder Cancer (HR-NMIBC) and Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy",
"has_exemption": false,
"start_date": "2024-04-26",
"completion_date": "2030-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04927416",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04927416",
"title": "The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05967351",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05967351",
"title": "A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarepta Therapeutics, Inc.",
"sponsor_slug": "sarepta-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06185673",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06185673",
"title": "A Phase 1b/2a, Open-label, Dose Escalation Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Benitec Biopharma, Inc.",
"sponsor_slug": "benitec-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06169371",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06169371",
"title": "Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)",
"has_exemption": false,
"start_date": "2023-12-28",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03704662",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03704662",
"title": "A Randomized, Phase II Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2018-10-22",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05863351",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05863351",
"title": "Phase III Randomized Trial of Stereotactic Ablative Radiotherapy (SAbR) for Oligometastatic Advanced Renal Carcinoma (SOAR)",
"has_exemption": false,
"start_date": "2023-09-07",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06124157",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06124157",
"title": "A Randomized International Phase 3 Trial of Imatinib and Chemotherapy With or Without Blinatumomab in Patients With Newly-Diagnosed Philadelphia Chromosome-Positive or Philadelphia Chromosome-Like ABL-Class B-Cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2024-01-22",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134167",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06134167",
"title": "A Prospective, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Effectiveness of the Transdermal Compress Device in Participants With Transfemoral Amputations",
"has_exemption": false,
"start_date": "2023-12-15",
"completion_date": "2030-12-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Balmoral Medical company",
"sponsor_slug": "balmoral-medical-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136650",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06136650",
"title": "A Phase 3, Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment With One Next-generation Hormonal Agent (NHA)",
"has_exemption": false,
"start_date": "2023-12-18",
"completion_date": "2030-12-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05450562",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05450562",
"title": "A Phase 1/2 Open-label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR444200-based Regimen in Participants With Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2022-09-20",
"completion_date": "2030-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03769415",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03769415",
"title": "HARMONY: Harnessing the Analysis of RNA Expression and Molecular Subtype to Optimize Novel TherapY for Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2018-11-06",
"completion_date": "2030-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03773965",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03773965",
"title": "A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)",
"has_exemption": false,
"start_date": "2019-04-05",
"completion_date": "2030-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03467958",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03467958",
"title": "A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2018-08-24",
"completion_date": "2030-12-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06190951",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06190951",
"title": "A Phase 2 Peri-operative Trial of Fianlimab and Cemiplimab Compared With Pembrolizumab in Patients With Resectable Stage III and IV Melanoma",
"has_exemption": false,
"start_date": "2024-02-09",
"completion_date": "2030-12-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01042379",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01042379",
"title": "I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)",
"has_exemption": false,
"start_date": "2010-03-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "QuantumLeap Healthcare Collaborative",
"sponsor_slug": "quantumleap-healthcare-collaborative",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03915015",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03915015",
"title": "VAPORHCS/OHSU J: Safety of Clinically Indicated Magnetic Resonance Imaging in Patients With Permanent Pacemakers (PPM) and Implanted Cardioverter Defibrillators (ICDs)",
"has_exemption": false,
"start_date": "2012-07-19",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01746836",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01746836",
"title": "Ponatinib as Second Line Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib, Dasatinib or Nilotinib",
"has_exemption": false,
"start_date": "2013-01-17",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02019706",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02019706",
"title": "Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome",
"has_exemption": false,
"start_date": "2014-02-12",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)",
"sponsor_slug": "eunice-kennedy-shriver-national-institute-of-child-health-and-human-development-nichd",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03868150",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03868150",
"title": "Assessment of Intra-Operative Atrial Fibrillation Inducibility As a Screening Tool to Prevent Post-Operative Atrial Fibrillation With Prophylaxis Amiodarone",
"has_exemption": false,
"start_date": "2017-03-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04106466",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04106466",
"title": "Deep Brain Stimulation (DBS) for Treatment Resistant Depression: Exploration of Local Field Potentials (LFPs) With the Medtronic Summit RC+S \"Brain Radio\" System",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Helen Mayberg, MD",
"sponsor_slug": "helen-mayberg-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05344833",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05344833",
"title": "Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma",
"has_exemption": false,
"start_date": "2023-01-05",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04203316",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04203316",
"title": "An Open-Label Feasibility Study to Assess the Safety and Pharmacokinetics of Enasidenib in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML) With an Isocitrate Dehydrogenase-2 (IDH2) Mutation",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06225596",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06225596",
"title": "A Randomized Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)",
"has_exemption": false,
"start_date": "2024-01-24",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BicycleTx Limited",
"sponsor_slug": "bicycletx-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03725059",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03725059",
"title": "A Randomized, Double-Blind, Phase III Study of Pembrolizumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (KEYNOTE-756)",
"has_exemption": false,
"start_date": "2018-12-27",
"completion_date": "2031-01-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03076658",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03076658",
"title": "Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers",
"has_exemption": false,
"start_date": "2016-09-30",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05371093",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05371093",
"title": "A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2022-09-12",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06185205",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06185205",
"title": "Accelerated Super-Hypofractionated Breast Brachytherapy - ASHBY Trial",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2031-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05050162",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05050162",
"title": "Randomized Phase II/III Trial of Radiation With High-Dose Cisplatin (100 mg/m2) Every Three Weeks Versus Radiation With Low-Dose Weekly Cisplatin (40 mg/m2) for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)",
"has_exemption": false,
"start_date": "2021-10-27",
"completion_date": "2031-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06057402",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06057402",
"title": "ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2031-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042140",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06042140",
"title": "Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair: Single Arm Phase III Trial.",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2031-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06045806",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06045806",
"title": "A Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9)",
"has_exemption": false,
"start_date": "2023-10-16",
"completion_date": "2031-03-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05235165",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05235165",
"title": "A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma",
"has_exemption": false,
"start_date": "2022-04-01",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05605899",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05605899",
"title": "An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel Versus Standard of Care Therapy as First-Line Therapy in Subjects With High-Risk Large B-Cell Lymphoma (ZUMA-23)",
"has_exemption": false,
"start_date": "2023-02-10",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05565105",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05565105",
"title": "A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Leukemia or Lymphoma",
"has_exemption": false,
"start_date": "2024-03-31",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05617625",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05617625",
"title": "A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome",
"has_exemption": false,
"start_date": "2024-03-31",
"completion_date": "2031-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05675410",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05675410",
"title": "A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2031-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03997786",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03997786",
"title": "A Multicenter, Randomized, Placebo and Active Comparator-controlled Clinical Trial to Study the Efficacy, Safety and Pharmacokinetics (PK) of Tildrakizumab in Pediatric Subjects From 6 to <18 Years of Age With Moderate to Severe Chronic Plaque Psoriasis",
"has_exemption": false,
"start_date": "2020-01-15",
"completion_date": "2031-05-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Pharmaceutical Industries Limited",
"sponsor_slug": "sun-pharmaceutical-industries-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02065011",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02065011",
"title": "An Open-label Study to Determine the Long-term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B",
"has_exemption": false,
"start_date": "2013-09-12",
"completion_date": "2031-06-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02919592",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02919592",
"title": "MemoryShape® and MemoryGel® Breast Implants Post Approval New Enrollment Study (\"Glow Study\")",
"has_exemption": false,
"start_date": "2016-09-01",
"completion_date": "2031-06-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Mentor Worldwide, LLC",
"sponsor_slug": "mentor-worldwide-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03424018",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03424018",
"title": "A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia",
"has_exemption": false,
"start_date": "2017-12-12",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04923126",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04923126",
"title": "SJ901: Phase 1/2 Evaluation of Single Agent Mirdametinib (PD-0325901), a Brain-Penetrant MEK1/2 Inhibitor, for the Treatment of Children, Adolescents, and Young Adults With Low-Grade Glioma",
"has_exemption": false,
"start_date": "2021-06-21",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940493",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05940493",
"title": "A Phase 2 Multicenter, Double-blind, Randomized-controlled Study of Abemaciclib (CDK4 and 6 Inhibitor) in Newly Diagnosed RB-proficient Grade 3 Meningioma Participants",
"has_exemption": false,
"start_date": "2023-10-15",
"completion_date": "2031-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nader Sanai",
"sponsor_slug": "nader-sanai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04990921",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04990921",
"title": "A Phase 2 Study of Palliative Radiation in Combination With Pembrolizumab in Subjects With Unresectable Metastatic Stage IV Breast Cancer: Twisted Pink",
"has_exemption": false,
"start_date": "2021-09-02",
"completion_date": "2031-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05905926",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05905926",
"title": "An Open-Label Long-Term Safety Study of Tenapanor for the Treatment of Irritable Bowel Syndrome With Constipation (IBS-C) in Pediatric Patients 6 to Less Than 18 Years Old",
"has_exemption": false,
"start_date": "2023-02-17",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ardelyx",
"sponsor_slug": "ardelyx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05907746",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05907746",
"title": "A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2031-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04982354",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04982354",
"title": "A Pilot Study of Daunorubicin-cytarabine Liposome (CPX-351) Plus FLT3-inhibitor (Midostaurin) as Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia Followed by Consolidation With a CD34+-Selected Allograft",
"has_exemption": false,
"start_date": "2022-07-05",
"completion_date": "2031-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072482",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06072482",
"title": "A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Subjects With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis",
"has_exemption": false,
"start_date": "2024-03-15",
"completion_date": "2031-08-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05442567",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05442567",
"title": "A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric Patients With Ulcerative Colitis or Crohn's Disease",
"has_exemption": false,
"start_date": "2023-05-16",
"completion_date": "2031-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00969111",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00969111",
"title": "Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy",
"has_exemption": false,
"start_date": "2009-08-31",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05505643",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05505643",
"title": "COOL-IT: Cryoablation vs Lumpectomy in T1 Breast Cancers: A Randomized Controlled Trial With Safety Lead-in",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2031-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06247995",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06247995",
"title": "A Phase I/II, Open-label, Multi-center Trial of [177Lu]Lu-NeoB in Combination With Capecitabine in Adult Patients With Gastrin Releasing Peptide Receptor Positive, Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor-2 Negative Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.",
"has_exemption": false,
"start_date": "2024-05-16",
"completion_date": "2031-09-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236438",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06236438",
"title": "A Randomized, Phase 2/3 Study to Evaluate the Optimal Dose, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2031-10-08",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205290",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06205290",
"title": "A Global Phase 3, Randomized, Open-label, Multi-center Trial Designed to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options (Idelalisib + Rituximab or Bendamustine + Rituximab) in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Whose Disease Has Failed Treatment With Both BTKi and BCL2i Targeted Therapies (A Double Class Exposed Population)",
"has_exemption": false,
"start_date": "2024-01-16",
"completion_date": "2031-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",
"sponsor_slug": "juno-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05624996",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05624996",
"title": "Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2023-05-10",
"completion_date": "2031-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04657822",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04657822",
"title": "An Open-label, Multi-center, Phase IV, Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study",
"has_exemption": false,
"start_date": "2021-06-10",
"completion_date": "2031-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05145010",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05145010",
"title": "Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Achondroplasia: PROPEL OLE",
"has_exemption": false,
"start_date": "2021-12-06",
"completion_date": "2031-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "QED Therapeutics, Inc.",
"sponsor_slug": "qed-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06133972",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06133972",
"title": "A Randomized, Double-blind, Placebo-controlled Extension Study to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)",
"has_exemption": false,
"start_date": "2024-05-17",
"completion_date": "2031-12-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01524211",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01524211",
"title": "Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms",
"has_exemption": false,
"start_date": "2012-01-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05478304",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05478304",
"title": "Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial",
"has_exemption": false,
"start_date": "2023-01-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AtriCure, Inc.",
"sponsor_slug": "atricure-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05885464",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05885464",
"title": "A Phase 1/2, Dose-Exploration and Dose-Expansion Study Evaluating the Safety and Efficacy of Multiplex Base-Edited, Allogeneic Anti-CD7 CAR-T Cells (BEAM-201) in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)",
"has_exemption": false,
"start_date": "2023-05-25",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beam Therapeutics Inc.",
"sponsor_slug": "beam-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134232",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06134232",
"title": "An Open -Label, Multicenter Study of Subjects With Metastatic Castrate-Resistant Prostate Cancer Treated With PROVENGE ® and Boosted With A Single Infusion of Sipuleucel-T to Measure Immune Response",
"has_exemption": false,
"start_date": "2023-11-27",
"completion_date": "2031-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dendreon",
"sponsor_slug": "dendreon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03687957",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03687957",
"title": "Effect of rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temzolomide",
"has_exemption": false,
"start_date": "2019-01-04",
"completion_date": "2032-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04165070",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04165070",
"title": "KEYMAKER-U01 Substudy 1: A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents With Pembrolizumab in Combination With Chemotherapy in Treatment-Naive Patients With Advanced Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2019-12-19",
"completion_date": "2032-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04165096",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04165096",
"title": "KEYMAKER-U01 Substudy 3: A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Anti-PD-(L)1 Therapy",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2032-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06140524",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06140524",
"title": "Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-04-30",
"completion_date": "2032-02-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06073821",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06073821",
"title": "A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2023-11-11",
"completion_date": "2032-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05295433",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05295433",
"title": "A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in the mRNA-3705-P101 Study",
"has_exemption": false,
"start_date": "2022-03-08",
"completion_date": "2032-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04114136",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04114136",
"title": "A Phase II Clinical Trial of Anti-PD-1 mAb Therapy Alone or With Metabolic Modulators to Reverse Tumor Hypoxia and Immune Dysfunction in Solid Tumor Malignancies",
"has_exemption": false,
"start_date": "2020-09-14",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dan Zandberg",
"sponsor_slug": "dan-zandberg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04093349",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04093349",
"title": "Phase 1/2, Dose-escalation Study to Evaluate the Safety, Tolerability and Efficacy of a Single Intravenous Infusion of SPK-3006 in Adults With Late-onset Pompe Disease",
"has_exemption": false,
"start_date": "2020-10-01",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Spark Therapeutics",
"sponsor_slug": "spark-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05050084",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05050084",
"title": "Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)",
"has_exemption": false,
"start_date": "2021-11-03",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05833763",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05833763",
"title": "An Open-label, Single-arm, Phase 2 Trial of GlOfitamab anD pIrtobrutinib (LOXo-305) in Patients With Mantle Cell Lymphoma and Prior Exposure to a BTK Inhibitor",
"has_exemption": false,
"start_date": "2023-10-12",
"completion_date": "2032-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Australasian Leukaemia and Lymphoma Group",
"sponsor_slug": "australasian-leukaemia-and-lymphoma-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03761108",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03761108",
"title": "Phase 1/2 FIH Study of REGN5458 (Anti-BCMA x Anti-CD3 Bispecific Antibody) in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2019-01-23",
"completion_date": "2032-05-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05564390",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05564390",
"title": "Master Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials",
"has_exemption": false,
"start_date": "2024-02-01",
"completion_date": "2032-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04557462",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04557462",
"title": "A Multicenter Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan in Adult Participants With Primary IgA Nephropathy Who Have Completed Study CLNP023X2203 or CLNP023A2301",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05630053",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05630053",
"title": "Randomized Controlled Trial to Compare Persona OsseoTi Keel Cementless TKA vs Persona Keel Cemented TKA",
"has_exemption": false,
"start_date": "2023-07-25",
"completion_date": "2032-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987449",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05987449",
"title": "A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2032-06-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03116529",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03116529",
"title": "Neoadjuvant Anti-PD-L1 (Durvalumab/MEDI4736) Plus Anti-CTLA-4 (Tremelimumab) and Radiation for High Risk Soft-Tissue Sarcoma",
"has_exemption": false,
"start_date": "2017-06-21",
"completion_date": "2032-06-21",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05468359",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05468359",
"title": "ANGIO-A: Safety and Tolerability of Oral Cyclophosphamide and Sorafenib With Intravenous Bevacizumab With the Addition of Atezolizumab in Pediatric Solid Tumor Patients",
"has_exemption": false,
"start_date": "2022-11-07",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05425615",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05425615",
"title": "Probing Language Processes Using Transcranial Magnetic Stimulation",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2032-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06087263",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06087263",
"title": "Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.",
"has_exemption": false,
"start_date": "2024-04-30",
"completion_date": "2032-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03033992",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03033992",
"title": "Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma or Ependymoma, and Feasibility and Efficacy Trial of Optune in Conjunction With Radiation Therapy for Children With Newly Diagnosed DIPG",
"has_exemption": false,
"start_date": "2017-04-04",
"completion_date": "2032-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Brain Tumor Consortium",
"sponsor_slug": "pediatric-brain-tumor-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03579901",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03579901",
"title": "Study of the Safety and Effectiveness of the Motiva Implants® Silicone Gel-Filled Breast Implants SmoothSilk® in Subjects Who Are Undergoing Primary Breast Augmentation, Primary Breast Reconstruction, and Revision Surgery",
"has_exemption": false,
"start_date": "2018-04-06",
"completion_date": "2032-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Motiva USA LLC",
"sponsor_slug": "motiva-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06145282",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06145282",
"title": "Non-myeloablative Phase I/II Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function",
"has_exemption": false,
"start_date": "2023-12-28",
"completion_date": "2032-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04589845",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04589845",
"title": "Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial",
"has_exemption": false,
"start_date": "2021-01-18",
"completion_date": "2032-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04687020",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04687020",
"title": "Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)",
"has_exemption": false,
"start_date": "2021-06-10",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NS Pharma, Inc.",
"sponsor_slug": "ns-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136559",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06136559",
"title": "A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2032-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04576130",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04576130",
"title": "A Danish Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients With Coronary Artery Disease Resuscitated From Ventricular Fibrillation Who Receive Complete Revascularization",
"has_exemption": false,
"start_date": "2020-10-12",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rigshospitalet, Denmark",
"sponsor_slug": "rigshospitalet-denmark",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05508009",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05508009",
"title": "Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRαβ+ T-cell/CD19+ B-cell Depletion for Patients Who Will Receive a Kidney Transplant (KT) From the Same HSCT/KT Donor",
"has_exemption": false,
"start_date": "2023-01-10",
"completion_date": "2032-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alice Bertaina",
"sponsor_slug": "alice-bertaina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05357482",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05357482",
"title": "Addition of JSP191 (C-kit Antibody) to Non-myeloablative Hematopoietic Cell Transplantation For Sickle Cell Disease and Beta-Thalassemia",
"has_exemption": false,
"start_date": "2022-05-12",
"completion_date": "2032-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05283720",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05283720",
"title": "Phase 1b/2, Open-Label Study to Evaluate Safety and Tolerability of Epcoritamab in Combination With Anti-Neoplastic Agents in Subjects With Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-06-14",
"completion_date": "2032-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128564",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06128564",
"title": "A Two-Part, Open-Label Systemic Gene Delivery Study to Evaluate the Safety and Expression of RO7494222 (SRP-9001) in Subjects Under the Age of Four With Duchenne Muscular Dystrophy",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2032-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05730036",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05730036",
"title": "An Open-label, Randomized, Phase 3 Study of Linvoseltamab (REGN5458; Anti- BCMA x Anti-CD3 Bispecific Antibody) Versus the Combination of Elotuzumab, Pomalidomide, and Dexamethasone (EPd), in Patients With Relapsed/Refractory Multiple Myeloma (LINKER-MM3)",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2032-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05767047",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05767047",
"title": "A Phase 3, Multicenter, Open-label, Long-term Extension Study of Apremilast in Children 2 Years of Age or Older With Oral Ulcers Associated With Behçet's Disease or 5 Years of Age or Older With Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2032-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03520660",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03520660",
"title": "Long-Term Follow-Up Of Subjects With CHC Who Achieved A Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents",
"has_exemption": false,
"start_date": "2018-10-19",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04423211",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04423211",
"title": "Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients With Post-ProstaTEctomy Biochemical Recurrence (INDICATE)",
"has_exemption": false,
"start_date": "2020-10-08",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04597359",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04597359",
"title": "A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers",
"has_exemption": false,
"start_date": "2021-10-05",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05659082",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05659082",
"title": "Cognition and Magnetic Resonance Imaging After Psychiatric Neurosurgery for Intractable Obsessive-Compulsive Disorder- Phase 2",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2032-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Butler Hospital",
"sponsor_slug": "butler-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06010030",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06010030",
"title": "A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia",
"has_exemption": false,
"start_date": "2023-08-25",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06052618",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06052618",
"title": "Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2033-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03003299",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03003299",
"title": "A Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve Implantation in Patients With a Failing Aortic Bioprosthetic Valve",
"has_exemption": false,
"start_date": "2017-01-05",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06048159",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06048159",
"title": "TACS for the Recovery of Phonological STM After Stroke",
"has_exemption": false,
"start_date": "2023-11-30",
"completion_date": "2033-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05786066",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05786066",
"title": "The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929768",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05929768",
"title": "Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2033-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05705453",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05705453",
"title": "Epidural Stimulation After Neurologic Damage: Long-Term Outcomes",
"has_exemption": false,
"start_date": "2023-03-01",
"completion_date": "2033-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01742299",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01742299",
"title": "An Open Label, Multi-center Imatinib Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Imatinib Study and Are Judged by the Investigator to Benefit From Continued Imatinib Treatment",
"has_exemption": false,
"start_date": "2013-03-26",
"completion_date": "2033-04-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01796795",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01796795",
"title": "A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Dose-ranging Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients.",
"has_exemption": false,
"start_date": "2030-09-30",
"completion_date": "2033-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "G&E Herbal Biotechnology Co., LTD",
"sponsor_slug": "ge-herbal-biotechnology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05591859",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05591859",
"title": "Restoration Anatomic Acetabular Shell Revision Study - A Post-market, Multi-center Evaluation of the Clinical Outcomes of the Restoration Anatomic Acetabular Shell in a Revision Indication",
"has_exemption": false,
"start_date": "2023-04-30",
"completion_date": "2033-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04731077",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04731077",
"title": "Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the Avenir Complete™ Femoral Stem (Implants and Instrumentation)",
"has_exemption": false,
"start_date": "2021-09-27",
"completion_date": "2033-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05947851",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05947851",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib (MK-1026) Plus Venetoclax Versus Venetoclax Plus Rituximab in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following at Least 1 Prior Therapy (BELLWAVE-010)",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2033-06-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02339571",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02339571",
"title": "Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma",
"has_exemption": false,
"start_date": "2015-11-23",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05257083",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05257083",
"title": "A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2033-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stichting European Myeloma Network",
"sponsor_slug": "stichting-european-myeloma-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236724",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06236724",
"title": "Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2033-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05803941",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05803941",
"title": "A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Adult Participants With Prostate Cancer",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2033-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02756962",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02756962",
"title": "Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance",
"has_exemption": false,
"start_date": "2016-07-06",
"completion_date": "2033-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04510597",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04510597",
"title": "Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)",
"has_exemption": false,
"start_date": "2021-03-08",
"completion_date": "2033-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05659381",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05659381",
"title": "GOG-3068: A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Cisplatin Versus no HIPEC at the Time of Optimal Interval Cytoreductive Surgery Followed by Niraparib Maintenance in Patients With Newly Diagnosed Stage III and IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (Heated Ovarian Treatment Trial)",
"has_exemption": false,
"start_date": "2023-12-11",
"completion_date": "2033-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "GOG Foundation",
"sponsor_slug": "gog-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04984291",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04984291",
"title": "Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2021-07-28",
"completion_date": "2033-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01736592",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01736592",
"title": "An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration",
"has_exemption": false,
"start_date": "2012-12-14",
"completion_date": "2033-08-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06055712",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06055712",
"title": "Antibiotic Prophylaxis in Pediatric Open Fractures",
"has_exemption": false,
"start_date": "2023-09-11",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Louis University",
"sponsor_slug": "st-louis-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05994235",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05994235",
"title": "A Phase II Trial of Tazemetostat Plus Mosunetuzumab in Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-11-01",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03755739",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03755739",
"title": "A Phase II/III Trial of Comparison of Benefit of Administration of Checkpoint Inhibitors Plus Chemodrug Via Artery or Fine Needle to Tumor Versus Vein for Immunotherapy of Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2018-11-01",
"completion_date": "2033-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04742634",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04742634",
"title": "A Phase I/II Trial of Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant",
"has_exemption": false,
"start_date": "2022-05-12",
"completion_date": "2033-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05642195",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05642195",
"title": "Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2033-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06179472",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06179472",
"title": "UnityPoint Health-Meriter Hospital (UPH-Meriter), the American Family Children's Hospital (AFCH), the UW Health Fetal Diagnosis and Treatment Center (FDTC), and the University of Wisconsin School of Medicine and Public Health",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2033-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04513717",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04513717",
"title": "Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)",
"has_exemption": false,
"start_date": "2020-12-15",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04754087",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04754087",
"title": "Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the G7 Acetabular System With Vivacit-E and Longevity Highly Crosslinked Polyethylene (HXLPE) Liners & Instrumentation",
"has_exemption": false,
"start_date": "2021-07-07",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05144191",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05144191",
"title": "Insignia™ Hip Stem Outcomes Study - A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia™ Hip Stem for Total Hip Replacement Surgery",
"has_exemption": false,
"start_date": "2022-02-07",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06031259",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06031259",
"title": "An Open-Label Extension for Subjects in Studies HGT-HIT-046 and SHP609-302 Evaluating Long-Term Safety of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase® in Subjects With Hunter Syndrome and Cognitive Impairment",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2034-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02106988",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02106988",
"title": "Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Patients With Stage I/II Nasal NK Cell Lymphoma",
"has_exemption": false,
"start_date": "2015-01-16",
"completion_date": "2034-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05977036",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05977036",
"title": "BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2034-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04817969",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04817969",
"title": "Persona® Ti-Nidium® Personalized Total Knee System A Post-Market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data Using the Persona Ti-Nidium Total Knee System and Instrumentation",
"has_exemption": false,
"start_date": "2021-06-01",
"completion_date": "2034-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06239272",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06239272",
"title": "NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2034-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05907759",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05907759",
"title": "A Phase II Study of Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma and Multicentric Castleman Disease",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2034-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06085742",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06085742",
"title": "BRE-08: A Phase II Study of an All-Oral Adjuvant Chemotherapy Regimen of Cyclophosphamide, Methotrexate, and Capecitabine (CMC) for Early-Stage Breast Cancer",
"has_exemption": false,
"start_date": "2023-11-22",
"completion_date": "2034-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06023641",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06023641",
"title": "A Protocol for the Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease",
"has_exemption": false,
"start_date": "2024-03-31",
"completion_date": "2034-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05898828",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05898828",
"title": "Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2034-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05307146",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05307146",
"title": "Study of Brain Activity in Candidates for Epilepsy Surgery",
"has_exemption": false,
"start_date": "2013-12-18",
"completion_date": "2035-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05535166",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05535166",
"title": "SJiMB21: Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2035-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828511",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05828511",
"title": "Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patients With Symptomatic Multiple Myeloma",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2035-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04042025",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04042025",
"title": "A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101",
"has_exemption": false,
"start_date": "2020-02-10",
"completion_date": "2035-12-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Gene Therapies",
"sponsor_slug": "novartis-gene-therapies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04699591",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04699591",
"title": "Compassionate Use of Domperidone for Refractory Gastroparesis",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Mercy Hospital Kansas City",
"sponsor_slug": "childrens-mercy-hospital-kansas-city",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03564678",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03564678",
"title": "Mitochondrial Cofactors for the Treatment of Hyperbilirubinemia Due to PEG-Asparaginase and or Inotuzumab Ozogamicin in Patients With Acute Lymphoblastic Leukemia (ALL)",
"has_exemption": false,
"start_date": "2018-05-17",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04074135",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04074135",
"title": "Evaluation of the Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2020-06-02",
"completion_date": "2036-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02445222",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02445222",
"title": "Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy",
"has_exemption": false,
"start_date": "2015-11-02",
"completion_date": "2036-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02201992",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02201992",
"title": "A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein",
"has_exemption": false,
"start_date": "2015-03-23",
"completion_date": "2036-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03935893",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03935893",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers",
"has_exemption": false,
"start_date": "2019-12-03",
"completion_date": "2036-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Udai Kammula",
"sponsor_slug": "udai-kammula",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03435796",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03435796",
"title": "Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells",
"has_exemption": false,
"start_date": "2018-06-19",
"completion_date": "2036-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05548972",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05548972",
"title": "Global, Multicenter and Prospective Post-Market Clinical Follow-Up Study of the G7® Dual Mobility Acetabular System With Vivacit-E® or Longevity® Poly Bearing & Instrumentation",
"has_exemption": false,
"start_date": "2023-03-20",
"completion_date": "2037-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02186418",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02186418",
"title": "Gene Transfer For Patients With Sickle Cell Disease Using A Gamma Globin Lentivirus Vector: An Open-Label Phase 1 / 2 Pilot Study",
"has_exemption": false,
"start_date": "2014-07-31",
"completion_date": "2037-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05201781",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05201781",
"title": "Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel",
"has_exemption": false,
"start_date": "2022-03-09",
"completion_date": "2037-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05281809",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05281809",
"title": "A Feasibility Study Following a Phase 2a Design to Demonstrate Successful Local Manufacture of Chimeric Antigen Receptor (CAR) T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2022-04-19",
"completion_date": "2037-08-05",
"has_results": false,
"results_due": false,
"sponsor_name": "John Lister",
"sponsor_slug": "john-lister",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05568719",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05568719",
"title": "A PHASE 3, NON-INVESTIGATIONAL PRODUCT, MULTI COUNTRY COHORT STUDY TO DESCRIBE THE LONG-TERM SAFETY AND EFFECTIVENESS OF A PRIOR SINGLE-DOSE TREATMENT WITH INVESTIGATIVE GIROCTOCOGENE FITELPARVOVEC OR FIDANACOGENE ELAPARVOVEC IN PARTICIPANTS WITH HEMOPHILIA A OR HEMOPHILIA B, RESPECTIVELY",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2037-11-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05587244",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05587244",
"title": "Multicenter, Prospective Post-Market Clinical Follow-Up Study of the G7® Freedom Constrained Vivacit-E® Liners",
"has_exemption": false,
"start_date": "2023-05-08",
"completion_date": "2037-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01770418",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01770418",
"title": "A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2013-03-31",
"completion_date": "2038-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03538899",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03538899",
"title": "A Phase I/II Feasibility Study of Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID) Using a Self-Inactivating Lentiviral Vector (AProArt) to Transduce Autologous CD34 Hematopoietic Cells",
"has_exemption": false,
"start_date": "2018-05-31",
"completion_date": "2038-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00912041",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00912041",
"title": "BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia",
"has_exemption": false,
"start_date": "2009-05-31",
"completion_date": "2038-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Leigh R. Hochberg, MD, PhD.",
"sponsor_slug": "leigh-r-hochberg-md-phd",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04081701",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04081701",
"title": "68Ga(Gallium)-DOTATATE Positron Emission Tomography (PET)/MRI in the Diagnosis and Management of Somatostatin Receptor Positive Central Nervous System CNS Tumors.",
"has_exemption": false,
"start_date": "2019-09-04",
"completion_date": "2038-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929807",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05929807",
"title": "A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents With Achondroplasia",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2039-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascendis Pharma Growth Disorders A/S",
"sponsor_slug": "ascendis-pharma-growth-disorders-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05689164",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05689164",
"title": "Long-term Follow-up Safety and Efficacy Study in Participants With Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in a Preceding Clinical Study",
"has_exemption": false,
"start_date": "2023-03-13",
"completion_date": "2039-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04208529",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04208529",
"title": "A Long-term Follow-up Study of Subjects With β-thalassemia or Sickle Cell Disease Treated With Autologous CRISPR-Cas9 Modified Hematopoietic Stem Cells (CTX001)",
"has_exemption": false,
"start_date": "2021-01-20",
"completion_date": "2039-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05335876",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05335876",
"title": "Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 IT or OAV101 IV in Clinical Trials",
"has_exemption": false,
"start_date": "2022-12-19",
"completion_date": "2039-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02598349",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02598349",
"title": "A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2016-04-30",
"completion_date": "2039-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03007589",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03007589",
"title": "Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics",
"has_exemption": false,
"start_date": "2014-04-30",
"completion_date": "2040-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Protection Foundation",
"sponsor_slug": "sun-protection-foundation",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05849480",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05849480",
"title": "A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2040-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02689440",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02689440",
"title": "Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib and Venetoclax: A Phase II Study",
"has_exemption": false,
"start_date": "2016-02-19",
"completion_date": "2040-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05041309",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05041309",
"title": "Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells",
"has_exemption": false,
"start_date": "2021-12-15",
"completion_date": "2041-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02760849",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02760849",
"title": "WISP (Women Choosing Surgical Prevention)",
"has_exemption": false,
"start_date": "2016-05-02",
"completion_date": "2041-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05962346",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05962346",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion for Severe Left Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2023-12-31",
"completion_date": "2043-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mauro H. Schenone",
"sponsor_slug": "mauro-h-schenone",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03486873",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03486873",
"title": "A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab",
"has_exemption": false,
"start_date": "2018-08-21",
"completion_date": "2043-08-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02917460",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02917460",
"title": "Genomic Biorepository: Protocol for the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2050-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rady Pediatric Genomics & Systems Medicine Institute",
"sponsor_slug": "rady-pediatric-genomics-systems-medicine-institute",
"status": "ongoing",
"is_pact": true,
"days_late": null
}
]
}